統一企業中國(00220.HK):上半年純利9.66億元 同比上升10.2%
格隆匯8月7日丨統一企業中國(00220.HK)發佈2024年中期業績公吿,報吿期內,收益為人民幣154.49億元,同比上升6.0%;集團毛利率為33.8%,上升2.7個百分點;未計利息、税項、折舊及攤銷前盈利為人民幣18.94億元,同比上升5.6%;公司權益持有人期間應占溢利為人民幣9.66億元,同比上升10.2%。
回顧期內,集團毛利額由去年同期增加至人民幣52.28億元,同比上升15.3%,毛利率由去年同期的31.1%上升2.7個百分點至33.8%,主要是部分原物料價格回落、產能效益提升、產品結構優化所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.